… aspirin for secondary prevention of cardiovascular disease (… ), and clopidogrel as an alternative
in case of aspirin resistance (IB … clopidogrel may be considered in preference to aspirin in …

… clopidogrel and ticlopidine were modestly more effective than aspirin for preventing serious
vascular events in patients … show that clopidogrel has favorable efficacy than aspirin, most of …

… CAD: coronary artery disease; CHF: congestive heart failure; … , and bleeding events compared
to aspirin in patients with … with clopidogrel over aspirin for secondary prevention in patients …

… ), clopidogrel in addition to … events than anticoagulation alone. Here, we describe the results
in cohort A of the trial, which compared aspirin alone with aspirin plus clopidogrel in patients …

… patient–level data from 2 large-scale randomized clinical trials that evaluated clopidogrel-aspirin
as a treatment to prevent … , race, previous ischemic heart disease, hypertension, diabe…

… dual antiplatelet therapy (DAPT) with clopidogrel-aspirin (CA) is more effective at preventing
early vascular events than aspirin monotherapy (AM) in patients with acute minor stroke or a …

… The risk of ischemic stroke and other major vascular events shortly after a minor acute …
Our findings suggest that for every 1000 patients treated, adding clopidogrel might prevent …

… regimen, the number needed to treat to prevent one MACE … of aspirin and extended-release
dipyridamole, which demonstrated significant reduction in major vascular events in patients …

… events between the ticagrelor/aspirin and clopidogrel/aspirin … Patients with acute minor
ischaemic stroke and transient … at high risk of recurrent stroke and cardiovascular events.The …

… to clopidogrel in preventing recurrent adverse cardiovascular … ) is increasing in patients with
coronary artery disease (CAD). … this invasive procedure compared to open-heart surgery [1]. …